Gude K - Search Results

1

Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms.

Sutter G, Schmelter T, Gude K, Schaefers M, Gerlinger C, Archer DF. Sutter G, et al. Among authors: gude k. Menopause. 2014 Mar;21(3):236-42. doi: 10.1097/GME.0b013e31829c12e8. Menopause. 2014. PMID: 23963309 Clinical Trial.

2

Recommendation for the collection and analysis of endometrial biopsies for hormone therapies.

Gerlinger C, Gude K, Alinčić-Kunz S, Schäfers M; Bayer Pharma AG - Global Clinical Statistics, Berlin, Germany. Gerlinger C, et al. Among authors: gude k. Climacteric. 2012 Feb;15(1):52-8. doi: 10.3109/13697137.2011.587055. Epub 2011 Sep 21. Climacteric. 2012. PMID: 21936612

3

An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.

Gerlinger C, Gude K, Hiemeyer F, Schmelter T, Schäfers M. Gerlinger C, et al. Among authors: gude k. Menopause. 2012 Jul;19(7):799-803. doi: 10.1097/gme.0b013e31823de8ba. Menopause. 2012. PMID: 22228322 Clinical Trial.

4

One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.

Genazzani AR, Schmelter T, Schaefers M, Gerlinger C, Gude K. Genazzani AR, et al. Among authors: gude k. Climacteric. 2013 Aug;16(4):490-8. doi: 10.3109/13697137.2013.783797. Epub 2013 May 11. Climacteric. 2013. PMID: 23531117 Clinical Trial.

5

A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.

Archer DF, Schmelter T, Schaefers M, Gerlinger C, Gude K. Archer DF, et al. Among authors: gude k. Menopause. 2014 Mar;21(3):227-35. doi: 10.1097/GME.0b013e31829c1431. Menopause. 2014. PMID: 23963307 Clinical Trial.

6

0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.

Gerlinger C, Gude K, Schmelter T, Schaefers M, Endrikat J. Gerlinger C, et al. Among authors: gude k. Climacteric. 2015;18(4):512-7. doi: 10.3109/13697137.2015.1036855. Epub 2015 May 22. Climacteric. 2015. PMID: 26000627

7

Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study.

Lang J, Yu Q, Zhang S, Li H, Gude K, von Ludwig C, Ren X, Dong L. Lang J, et al. Among authors: gude k. J Womens Health (Larchmt). 2018 Feb;27(2):148-155. doi: 10.1089/jwh.2017.6399. Epub 2017 Oct 30. J Womens Health (Larchmt). 2018. PMID: 29083258 Clinical Trial.

8

Reevaluating response and failure of medical treatment of endometriosis: a systematic review.

Becker CM, Gattrell WT, Gude K, Singh SS. Becker CM, et al. Among authors: gude k. Fertil Steril. 2017 Jul;108(1):125-136. doi: 10.1016/j.fertnstert.2017.05.004. Fertil Steril. 2017. PMID: 28668150 Free PMC article. Review.

9

Surgical Outcomes in Patients With Endometriosis: A Systematic Review.

Singh SS, Gude K, Perdeaux E, Gattrell WT, Becker CM. Singh SS, et al. Among authors: gude k. J Obstet Gynaecol Can. 2020 Jul;42(7):881-888.e11. doi: 10.1016/j.jogc.2019.08.004. Epub 2019 Nov 9. J Obstet Gynaecol Can. 2020. PMID: 31718952 Free article. Review.

10

Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.

Ebert AD, Dong L, Merz M, Kirsch B, Francuski M, Böttcher B, Roman H, Suvitie P, Hlavackova O, Gude K, Seitz C. Ebert AD, et al. Among authors: gude k. J Pediatr Adolesc Gynecol. 2017 Oct;30(5):560-567. doi: 10.1016/j.jpag.2017.01.014. Epub 2017 Feb 9. J Pediatr Adolesc Gynecol. 2017. PMID: 28189702 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page